StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by Skrit37on Nov 12, 2020 8:17pm

778 Views

Post# 31892325

When I feal glum

and dont agree with something that going on with SZ....i take the time and re read the prospectus or listen to the q2 CC or SNN CC...

There is ooodles of "recent" informative / uplifting info in them ....and most importantly its straight from the cats Meow....

Then you can interprit it whichever way you wish....but to me, the path forward cannot be anymore clear

Goodluck Folks

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks